News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Insulet Corporation Posts Narrower Q2 Loss
August 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Insulet Corp posted a narrower quarterly loss, helped by a rise in referrals and improved gross margins, and it also raised the lower end of its 2009 revenue outlook, sending its shares up 15 percent in after-market trade.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Pancreatic cancer
ESMO 2026: Tango trips on sinking response rates in pancreatic cancer but will move to Phase 3
October 23, 2026
·
4 min read
·
Heather McKenzie
Layoff Tracker
Tango plans 14% workforce cut, mainly of research staff
October 23, 2026
·
107 min read
·
BioSpace Editorial Staff
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
·
2 min read
·
Nick Paul Taylor
Immunology and inflammation
Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStar
October 23, 2026
·
1 min read
·
Annalee Armstrong